OFD1P3Y

Across TCGA pan-cancer cohorts, OFD1P3Y RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OFD1P3Y data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OFD1P3Y RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OFD1P3Y expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

BLCA, KIRC, and OV are the cancer types where OFD1P3Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.203	0.525	.014	54	view →
KIRC	DFS	Tertile	IV	0.234	0.633	.005	36	view →
OV	DFS	Tertile	All	0.142	0.541	.002	36	view →
ESCA	DFS	Tertile	III,IV	0.513	0.257	.035	24	view →
PCPG	OS	Tertile	All	0.723	0.975	.008	18	view →
PRAD	DFS	Tertile	All	0.722	0.891	.013	18	view →
THCA	DFS	Tertile	III,IV	0.116	0.897	<.001	18	view →
LIHC	DFS	Tertile	II,III,IV	0.247	0.434	.030	18	view →
STAD	DFS	Tertile	All	0.735	0.598	.034	6	view →
LGG	DFS	Tertile	All	0.456	0.742	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OFD1P3Y–BLCA (DFS)

Open the BLCA breakdown →